Fundraising FoxOCV Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware.
BiotechHealthtechMedical DevicesNew MaterialsPalmetto, US
Orahn Preiss-Bloom(Founder & Chief Innovation Officer)inBrian Verrier(Chief Executive Officer)inBrennan Marilla(Chief Commercial and Operating Officer)inMoshe Shneor(Chief Financial Officer)inGregory C. Berlet(Chief Medical Officer)
Co-investorsMVM Life Science PartnersQuesta CapitalSecocha Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.